Product
l-leucovorin
Aliases
I-LV
1 clinical trial
3 indications
Indication
Stomach CancerIndication
Esophageal CancerIndication
Pancreatic adenocarcinomaClinical trial
A Phase II, Open-label, Multi-centre Study to Evaluate Safety, Tolerability, Efficacy, PK, and Immunogenicity of AZD0901 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Tumours Expressing Claudin 18.2.Status: Recruiting, Estimated PCD: 2025-05-02